VLX103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VLX103, covering 2018-05-30 to 2018-05-30. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis [Phase 1]